Rank | Gene Set | Z-score |
---|---|---|
1 | ribosomal small subunit assembly (GO:0000028) | 8.12543739 |
2 | viral transcription (GO:0019083) | 6.09078071 |
3 | glyoxylate metabolic process (GO:0046487) | 5.85501254 |
4 | translational termination (GO:0006415) | 5.80244971 |
5 | DNA deamination (GO:0045006) | 5.72585441 |
6 | translational elongation (GO:0006414) | 5.19867079 |
7 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.17074151 |
8 | cotranslational protein targeting to membrane (GO:0006613) | 5.04731832 |
9 | protein targeting to ER (GO:0045047) | 5.02451938 |
10 | ribosomal small subunit biogenesis (GO:0042274) | 4.91613625 |
11 | protein localization to endoplasmic reticulum (GO:0070972) | 4.85310253 |
12 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.77803378 |
13 | viral life cycle (GO:0019058) | 4.43849208 |
14 | maturation of SSU-rRNA (GO:0030490) | 4.33532014 |
15 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.31803854 |
16 | cellular protein complex disassembly (GO:0043624) | 4.27317711 |
17 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.23875049 |
18 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.23875049 |
19 | platelet dense granule organization (GO:0060155) | 4.19180915 |
20 | amyloid precursor protein catabolic process (GO:0042987) | 4.08252956 |
21 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.06185099 |
22 | translational initiation (GO:0006413) | 4.05595009 |
23 | complement activation, alternative pathway (GO:0006957) | 3.89925312 |
24 | serine family amino acid catabolic process (GO:0009071) | 3.85895570 |
25 | response to interferon-beta (GO:0035456) | 3.80087879 |
26 | epoxygenase P450 pathway (GO:0019373) | 3.79553112 |
27 | protein carboxylation (GO:0018214) | 3.78983904 |
28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.78983904 |
29 | blood coagulation, intrinsic pathway (GO:0007597) | 3.78262312 |
30 | drug catabolic process (GO:0042737) | 3.70302059 |
31 | protein complex disassembly (GO:0043241) | 3.66997196 |
32 | L-phenylalanine metabolic process (GO:0006558) | 3.64861162 |
33 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.64861162 |
34 | definitive hemopoiesis (GO:0060216) | 3.63109640 |
35 | regulation of fibrinolysis (GO:0051917) | 3.60291094 |
36 | arginine catabolic process (GO:0006527) | 3.57558107 |
37 | negative regulation of cholesterol transport (GO:0032375) | 3.56438534 |
38 | negative regulation of sterol transport (GO:0032372) | 3.56438534 |
39 | pentose metabolic process (GO:0019321) | 3.52488490 |
40 | aldehyde catabolic process (GO:0046185) | 3.52304645 |
41 | oxidative phosphorylation (GO:0006119) | 3.50228246 |
42 | L-serine metabolic process (GO:0006563) | 3.48078046 |
43 | bile acid biosynthetic process (GO:0006699) | 3.47153761 |
44 | macromolecular complex disassembly (GO:0032984) | 3.46798808 |
45 | fibrinolysis (GO:0042730) | 3.46594672 |
46 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.44481571 |
47 | doxorubicin metabolic process (GO:0044598) | 3.43498737 |
48 | daunorubicin metabolic process (GO:0044597) | 3.43498737 |
49 | polyketide metabolic process (GO:0030638) | 3.43498737 |
50 | pseudouridine synthesis (GO:0001522) | 3.41637046 |
51 | glycosphingolipid catabolic process (GO:0046479) | 3.40728471 |
52 | ribosomal large subunit biogenesis (GO:0042273) | 3.40055902 |
53 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.37890853 |
54 | phospholipid efflux (GO:0033700) | 3.37679228 |
55 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.35220517 |
56 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.34108495 |
57 | translation (GO:0006412) | 3.34024110 |
58 | oxidative demethylation (GO:0070989) | 3.31437440 |
59 | omega-hydroxylase P450 pathway (GO:0097267) | 3.29200722 |
60 | proteasome assembly (GO:0043248) | 3.27554238 |
61 | L-phenylalanine catabolic process (GO:0006559) | 3.27347614 |
62 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.27347614 |
63 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.25832249 |
64 | protein targeting to membrane (GO:0006612) | 3.25515903 |
65 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.24094424 |
66 | negative regulation of fibrinolysis (GO:0051918) | 3.23532707 |
67 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.22707284 |
68 | alkaloid metabolic process (GO:0009820) | 3.18684677 |
69 | cysteine metabolic process (GO:0006534) | 3.17034730 |
70 | heme biosynthetic process (GO:0006783) | 3.16436090 |
71 | heme metabolic process (GO:0042168) | 3.12642109 |
72 | metallo-sulfur cluster assembly (GO:0031163) | 3.11571346 |
73 | iron-sulfur cluster assembly (GO:0016226) | 3.11571346 |
74 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.10083859 |
75 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.10083859 |
76 | positive regulation of respiratory burst (GO:0060267) | 3.08683468 |
77 | mRNA catabolic process (GO:0006402) | 3.07503129 |
78 | tyrosine metabolic process (GO:0006570) | 3.06185206 |
79 | glycolipid catabolic process (GO:0019377) | 3.04691856 |
80 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.02234981 |
81 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.02234981 |
82 | NADH dehydrogenase complex assembly (GO:0010257) | 3.02234981 |
83 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.02129730 |
84 | aromatic amino acid family metabolic process (GO:0009072) | 3.01941382 |
85 | arginine metabolic process (GO:0006525) | 3.00991178 |
86 | respiratory chain complex IV assembly (GO:0008535) | 3.00582878 |
87 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.00415215 |
88 | amine catabolic process (GO:0009310) | 3.00404070 |
89 | cellular biogenic amine catabolic process (GO:0042402) | 3.00404070 |
90 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.99058627 |
91 | regulation of protein activation cascade (GO:2000257) | 2.98884367 |
92 | protein complex biogenesis (GO:0070271) | 2.98846131 |
93 | amino sugar catabolic process (GO:0046348) | 2.98364011 |
94 | xenobiotic catabolic process (GO:0042178) | 2.96870480 |
95 | serine family amino acid metabolic process (GO:0009069) | 2.96167447 |
96 | N-acetylneuraminate metabolic process (GO:0006054) | 2.94505533 |
97 | phenylpropanoid metabolic process (GO:0009698) | 2.94327733 |
98 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.93140036 |
99 | aerobic respiration (GO:0009060) | 2.93070214 |
100 | plasma lipoprotein particle clearance (GO:0034381) | 2.92692014 |
101 | cholesterol efflux (GO:0033344) | 2.90986266 |
102 | endosome to melanosome transport (GO:0035646) | 2.90479796 |
103 | endosome to pigment granule transport (GO:0043485) | 2.90479796 |
104 | regulation of triglyceride catabolic process (GO:0010896) | 2.89218165 |
105 | oligosaccharide catabolic process (GO:0009313) | 2.86592395 |
106 | ceramide catabolic process (GO:0046514) | 2.85768030 |
107 | exogenous drug catabolic process (GO:0042738) | 2.85118607 |
108 | RNA catabolic process (GO:0006401) | 2.84892969 |
109 | cellular component biogenesis (GO:0044085) | 2.84678933 |
110 | glycine metabolic process (GO:0006544) | 2.84353741 |
111 | DNA strand elongation (GO:0022616) | 2.83266106 |
112 | regulation of mitochondrial translation (GO:0070129) | 2.82878812 |
113 | cofactor catabolic process (GO:0051187) | 2.82738331 |
114 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.82197051 |
115 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.81989184 |
116 | drug metabolic process (GO:0017144) | 2.81609570 |
117 | protein-lipid complex remodeling (GO:0034368) | 2.80330169 |
118 | macromolecular complex remodeling (GO:0034367) | 2.80330169 |
119 | plasma lipoprotein particle remodeling (GO:0034369) | 2.80330169 |
120 | aromatic amino acid family catabolic process (GO:0009074) | 2.80297269 |
121 | lysine metabolic process (GO:0006553) | 2.77707745 |
122 | lysine catabolic process (GO:0006554) | 2.77707745 |
123 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.77564990 |
124 | purine-containing compound salvage (GO:0043101) | 2.76634022 |
125 | tryptophan catabolic process (GO:0006569) | 2.76164897 |
126 | indole-containing compound catabolic process (GO:0042436) | 2.76164897 |
127 | indolalkylamine catabolic process (GO:0046218) | 2.76164897 |
128 | positive regulation of prostaglandin secretion (GO:0032308) | 2.75247628 |
129 | bile acid metabolic process (GO:0008206) | 2.74601113 |
130 | acylglycerol homeostasis (GO:0055090) | 2.73023619 |
131 | triglyceride homeostasis (GO:0070328) | 2.73023619 |
132 | cellular amino acid catabolic process (GO:0009063) | 2.71399227 |
133 | regulation of complement activation (GO:0030449) | 2.69331157 |
134 | serine family amino acid biosynthetic process (GO:0009070) | 2.69297027 |
135 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.68910837 |
136 | GDP-mannose metabolic process (GO:0019673) | 2.68723983 |
137 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.68554102 |
138 | organic acid catabolic process (GO:0016054) | 2.67419142 |
139 | carboxylic acid catabolic process (GO:0046395) | 2.67419142 |
140 | response to interferon-alpha (GO:0035455) | 2.64930961 |
141 | flavonoid metabolic process (GO:0009812) | 2.64829415 |
142 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.64125168 |
143 | purine nucleotide salvage (GO:0032261) | 2.64028698 |
144 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.62215010 |
145 | dopamine transport (GO:0015872) | 2.62162781 |
146 | high-density lipoprotein particle remodeling (GO:0034375) | 2.61974730 |
147 | cellular metabolic compound salvage (GO:0043094) | 2.60998244 |
148 | nucleoside salvage (GO:0043174) | 2.60977153 |
149 | alpha-amino acid catabolic process (GO:1901606) | 2.60771723 |
150 | sulfur amino acid catabolic process (GO:0000098) | 2.59557661 |
151 | nucleotide salvage (GO:0043173) | 2.59209999 |
152 | secretory granule organization (GO:0033363) | 2.59199032 |
153 | L-methionine salvage (GO:0071267) | 2.58668426 |
154 | L-methionine biosynthetic process (GO:0071265) | 2.58668426 |
155 | amino acid salvage (GO:0043102) | 2.58668426 |
156 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.58617523 |
157 | proline metabolic process (GO:0006560) | 2.57890855 |
158 | sphingolipid catabolic process (GO:0030149) | 2.55889229 |
159 | protein autoprocessing (GO:0016540) | 2.55157592 |
160 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.54990596 |
161 | vitamin biosynthetic process (GO:0009110) | 2.54668526 |
162 | telomere maintenance via recombination (GO:0000722) | 2.54281686 |
163 | valine metabolic process (GO:0006573) | 2.54105912 |
164 | steroid catabolic process (GO:0006706) | 2.53822467 |
165 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.51857781 |
166 | ATP synthesis coupled proton transport (GO:0015986) | 2.51857781 |
167 | drug transmembrane transport (GO:0006855) | 2.51837809 |
168 | toxin transport (GO:1901998) | 2.51175496 |
169 | monocarboxylic acid catabolic process (GO:0072329) | 2.51125182 |
170 | regulation of cholesterol esterification (GO:0010872) | 2.51040096 |
171 | sulfur amino acid biosynthetic process (GO:0000097) | 2.51000680 |
172 | ethanol oxidation (GO:0006069) | 2.50055803 |
173 | membrane lipid catabolic process (GO:0046466) | 2.50006658 |
174 | drug transport (GO:0015893) | 2.49171297 |
175 | urea cycle (GO:0000050) | 2.48959564 |
176 | urea metabolic process (GO:0019627) | 2.48959564 |
177 | amyloid precursor protein metabolic process (GO:0042982) | 2.48677466 |
178 | nitrogen cycle metabolic process (GO:0071941) | 2.48063697 |
179 | positive regulation of icosanoid secretion (GO:0032305) | 2.47813539 |
180 | uronic acid metabolic process (GO:0006063) | 2.45272322 |
181 | glucuronate metabolic process (GO:0019585) | 2.45272322 |
182 | vitamin D metabolic process (GO:0042359) | 2.44115407 |
183 | acute-phase response (GO:0006953) | 2.43050412 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.15655639 |
2 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.14563851 |
3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.83199363 |
4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.78179039 |
5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.06569053 |
6 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.05270578 |
7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.94143317 |
8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.82377107 |
9 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.68341554 |
10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.64812944 |
11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.63768220 |
12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.63510369 |
13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.59623830 |
14 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.58249234 |
15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.50660239 |
16 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.49614096 |
17 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.47491113 |
18 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.43746420 |
19 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.43539904 |
20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.43206955 |
21 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.41757474 |
22 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.41289237 |
23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.40943888 |
24 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.38927386 |
25 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.32160949 |
26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30863961 |
27 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.29517658 |
28 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.21939758 |
29 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.21783559 |
30 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.13900636 |
31 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.04623207 |
32 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.02590754 |
33 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.01309925 |
34 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.97488458 |
35 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.92784879 |
36 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.92735881 |
37 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.92675909 |
38 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.92040476 |
39 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.91777682 |
40 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.90611599 |
41 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.90274918 |
42 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.87602404 |
43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84175879 |
44 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.83891629 |
45 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.81793034 |
46 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.81437609 |
47 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.76013883 |
48 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.73689004 |
49 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.72046023 |
50 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71882530 |
51 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.71016990 |
52 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.69262549 |
53 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.68777400 |
54 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.63820707 |
55 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.59026301 |
56 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.58586026 |
57 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.58457002 |
58 | P68_20966046_ChIP-Seq_HELA_Human | 1.57431517 |
59 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.57065396 |
60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.53884409 |
61 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.53339872 |
62 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.52793076 |
63 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.49768920 |
64 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.49149899 |
65 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.48280649 |
66 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46797618 |
67 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.46363828 |
68 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.43905645 |
69 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.43360405 |
70 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.41050000 |
71 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.40481451 |
72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.40301578 |
73 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40029763 |
74 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.39721315 |
75 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.37694146 |
76 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.37364527 |
77 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.37165819 |
78 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36873651 |
79 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.36582227 |
80 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.35926920 |
81 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.35329129 |
82 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.35314679 |
83 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.34835407 |
84 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.34307933 |
85 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.34221838 |
86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33522512 |
87 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.32155042 |
88 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.31662908 |
89 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.31505454 |
90 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30975981 |
91 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29138818 |
92 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.28630716 |
93 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.26556391 |
94 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.26080620 |
95 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.26057398 |
96 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.25565546 |
97 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.25231997 |
98 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.24373652 |
99 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.24212270 |
100 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.24043749 |
101 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23869609 |
102 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23277115 |
103 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.22565090 |
104 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.21820527 |
105 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21320290 |
106 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.20284300 |
107 | MYC_22102868_ChIP-Seq_BL_Human | 1.19288854 |
108 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16959983 |
109 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.16689800 |
110 | * STAT1_20625510_ChIP-Seq_HELA_Human | 1.16280354 |
111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16217341 |
112 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15587846 |
113 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15395919 |
114 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13224460 |
115 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.13122548 |
116 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12434029 |
117 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.11250223 |
118 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.11155022 |
119 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.10603480 |
120 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.08683358 |
121 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08585929 |
122 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.07951128 |
123 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.07066836 |
124 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.05330665 |
125 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.04393067 |
126 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.04057226 |
127 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.02224061 |
128 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.02046054 |
129 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.02005524 |
130 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01767941 |
131 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01482979 |
132 | P300_27268052_Chip-Seq_Bcells_Human | 1.01468454 |
133 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00867473 |
134 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.00415509 |
135 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.00410533 |
136 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.00149022 |
137 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00057866 |
138 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.99456574 |
139 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.98776147 |
140 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98469441 |
141 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97849716 |
142 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96742437 |
143 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.96734156 |
144 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.93395297 |
145 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.92283154 |
146 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.88260671 |
147 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.87926514 |
148 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.86991588 |
149 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86246670 |
150 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.85734037 |
151 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.85518252 |
152 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.83798495 |
153 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.83627040 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.57156815 |
2 | MP0005058_abnormal_lysosome_morphology | 4.49983729 |
3 | MP0005360_urolithiasis | 3.78233866 |
4 | MP0005085_abnormal_gallbladder_physiolo | 3.72749377 |
5 | MP0003806_abnormal_nucleotide_metabolis | 3.67644267 |
6 | MP0005365_abnormal_bile_salt | 3.66470248 |
7 | MP0004147_increased_porphyrin_level | 3.53846609 |
8 | MP0003656_abnormal_erythrocyte_physiolo | 3.50816347 |
9 | MP0009379_abnormal_foot_pigmentation | 3.33088412 |
10 | MP0002396_abnormal_hematopoietic_system | 2.92818999 |
11 | MP0005397_hematopoietic_system_phenotyp | 2.73278326 |
12 | MP0001545_abnormal_hematopoietic_system | 2.73278326 |
13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.69864485 |
14 | MP0003186_abnormal_redox_activity | 2.52050610 |
15 | MP0006036_abnormal_mitochondrial_physio | 2.48114017 |
16 | MP0006054_spinal_hemorrhage | 2.47721854 |
17 | MP0003724_increased_susceptibility_to | 2.24557590 |
18 | MP0000604_amyloidosis | 2.13433858 |
19 | MP0003172_abnormal_lysosome_physiology | 2.12560601 |
20 | MP0003075_altered_response_to | 2.10082654 |
21 | MP0001666_abnormal_nutrient_absorption | 2.02574746 |
22 | MP0005464_abnormal_platelet_physiology | 2.01994654 |
23 | MP0010329_abnormal_lipoprotein_level | 1.96730270 |
24 | MP0002132_abnormal_respiratory_system | 1.91860986 |
25 | MP0002148_abnormal_hypersensitivity_rea | 1.91787350 |
26 | MP0009697_abnormal_copulation | 1.89736139 |
27 | MP0005075_abnormal_melanosome_morpholog | 1.88831746 |
28 | MP0001764_abnormal_homeostasis | 1.86942722 |
29 | MP0009840_abnormal_foam_cell | 1.85527593 |
30 | MP0005174_abnormal_tail_pigmentation | 1.85209732 |
31 | MP0000490_abnormal_crypts_of | 1.83428499 |
32 | MP0004808_abnormal_hematopoietic_stem | 1.80805205 |
33 | MP0005083_abnormal_biliary_tract | 1.77564461 |
34 | MP0005332_abnormal_amino_acid | 1.73355663 |
35 | MP0003191_abnormal_cellular_cholesterol | 1.73330923 |
36 | MP0001835_abnormal_antigen_presentation | 1.73038682 |
37 | MP0005319_abnormal_enzyme/_coenzyme | 1.72930547 |
38 | MP0006082_CNS_inflammation | 1.69443356 |
39 | MP0000465_gastrointestinal_hemorrhage | 1.68381607 |
40 | MP0003868_abnormal_feces_composition | 1.63100178 |
41 | MP0002876_abnormal_thyroid_physiology | 1.59615217 |
42 | MP0005636_abnormal_mineral_homeostasis | 1.54257759 |
43 | MP0005451_abnormal_body_composition | 1.52851449 |
44 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.50794497 |
45 | MP0001873_stomach_inflammation | 1.50529327 |
46 | MP0006035_abnormal_mitochondrial_morpho | 1.49460299 |
47 | MP0003252_abnormal_bile_duct | 1.45776271 |
48 | MP0008469_abnormal_protein_level | 1.36468376 |
49 | MP0003303_peritoneal_inflammation | 1.34090954 |
50 | MP0000609_abnormal_liver_physiology | 1.33283696 |
51 | MP0001853_heart_inflammation | 1.33076337 |
52 | MP0009785_altered_susceptibility_to | 1.31891519 |
53 | MP0003436_decreased_susceptibility_to | 1.31670839 |
54 | MP0005220_abnormal_exocrine_pancreas | 1.31117104 |
55 | MP0000685_abnormal_immune_system | 1.30649876 |
56 | MP0003693_abnormal_embryo_hatching | 1.29180739 |
57 | MP0001986_abnormal_taste_sensitivity | 1.28863386 |
58 | MP0003763_abnormal_thymus_physiology | 1.27486030 |
59 | MP0002837_dystrophic_cardiac_calcinosis | 1.27038769 |
60 | MP0002254_reproductive_system_inflammat | 1.26828811 |
61 | MP0000678_abnormal_parathyroid_gland | 1.25932081 |
62 | MP0002095_abnormal_skin_pigmentation | 1.24755399 |
63 | MP0000681_abnormal_thyroid_gland | 1.24150843 |
64 | MP0009643_abnormal_urine_homeostasis | 1.23300016 |
65 | MP0003866_abnormal_defecation | 1.21536058 |
66 | MP0005166_decreased_susceptibility_to | 1.18670078 |
67 | MP0010155_abnormal_intestine_physiology | 1.17153812 |
68 | MP0003879_abnormal_hair_cell | 1.16871827 |
69 | MP0000598_abnormal_liver_morphology | 1.16665579 |
70 | MP0000689_abnormal_spleen_morphology | 1.15398623 |
71 | MP0005084_abnormal_gallbladder_morpholo | 1.15106024 |
72 | MP0003329_amyloid_beta_deposits | 1.14812320 |
73 | MP0002398_abnormal_bone_marrow | 1.13470497 |
74 | MP0003011_delayed_dark_adaptation | 1.13370516 |
75 | MP0005671_abnormal_response_to | 1.13278817 |
76 | MP0002653_abnormal_ependyma_morphology | 1.12403516 |
77 | MP0005025_abnormal_response_to | 1.10988978 |
78 | MP0004957_abnormal_blastocyst_morpholog | 1.09366318 |
79 | MP0002118_abnormal_lipid_homeostasis | 1.07610926 |
80 | MP0009278_abnormal_bone_marrow | 1.05848415 |
81 | MP0001663_abnormal_digestive_system | 1.04709157 |
82 | MP0008260_abnormal_autophagy | 1.04588067 |
83 | MP0002166_altered_tumor_susceptibility | 1.04283418 |
84 | MP0002722_abnormal_immune_system | 1.04200209 |
85 | MP0005408_hypopigmentation | 1.03368456 |
86 | MP0002429_abnormal_blood_cell | 1.00673904 |
87 | MP0004510_myositis | 0.97977606 |
88 | MP0003638_abnormal_response/metabolism_ | 0.96305583 |
89 | MP0009333_abnormal_splenocyte_physiolog | 0.95582792 |
90 | MP0009763_increased_sensitivity_to | 0.94069832 |
91 | MP0009764_decreased_sensitivity_to | 0.91432019 |
92 | MP0002234_abnormal_pharynx_morphology | 0.89534861 |
93 | MP0008007_abnormal_cellular_replicative | 0.88514892 |
94 | MP0009642_abnormal_blood_homeostasis | 0.87238605 |
95 | MP0004019_abnormal_vitamin_homeostasis | 0.87005074 |
96 | MP0008872_abnormal_physiological_respon | 0.86628772 |
97 | MP0005379_endocrine/exocrine_gland_phen | 0.85367205 |
98 | MP0000716_abnormal_immune_system | 0.84330340 |
99 | MP0001533_abnormal_skeleton_physiology | 0.84049393 |
100 | MP0003195_calcinosis | 0.81998119 |
101 | MP0005165_increased_susceptibility_to | 0.81313369 |
102 | MP0001790_abnormal_immune_system | 0.81191747 |
103 | MP0005387_immune_system_phenotype | 0.81191747 |
104 | MP0010094_abnormal_chromosome_stability | 0.81112169 |
105 | MP0002090_abnormal_vision | 0.80804717 |
106 | MP0001756_abnormal_urination | 0.80651388 |
107 | MP0001845_abnormal_inflammatory_respons | 0.80604894 |
108 | MP0003943_abnormal_hepatobiliary_system | 0.80529141 |
109 | MP0001348_abnormal_lacrimal_gland | 0.79991885 |
110 | MP0005000_abnormal_immune_tolerance | 0.79484575 |
111 | MP0002723_abnormal_immune_serum | 0.78354853 |
112 | MP0001800_abnormal_humoral_immune | 0.77232465 |
113 | MP0005535_abnormal_body_temperature | 0.77065886 |
114 | MP0004215_abnormal_myocardial_fiber | 0.76604141 |
115 | MP0010386_abnormal_urinary_bladder | 0.75677777 |
116 | MP0005167_abnormal_blood-brain_barrier | 0.75076175 |
117 | MP0005266_abnormal_metabolism | 0.74929911 |
118 | MP0000343_altered_response_to | 0.73882378 |
119 | MP0005376_homeostasis/metabolism_phenot | 0.73729657 |
120 | MP0000358_abnormal_cell_content/ | 0.73719972 |
121 | MP0002420_abnormal_adaptive_immunity | 0.73438351 |
122 | MP0008058_abnormal_DNA_repair | 0.72809592 |
123 | MP0002138_abnormal_hepatobiliary_system | 0.72348199 |
124 | MP0001819_abnormal_immune_cell | 0.70824467 |
125 | MP0002019_abnormal_tumor_incidence | 0.70163878 |
126 | MP0001881_abnormal_mammary_gland | 0.70136999 |
127 | MP0002452_abnormal_antigen_presenting | 0.70051198 |
128 | MP0001905_abnormal_dopamine_level | 0.69902759 |
129 | MP0000313_abnormal_cell_death | 0.69535027 |
130 | MP0003077_abnormal_cell_cycle | 0.68989474 |
131 | MP0010368_abnormal_lymphatic_system | 0.68479796 |
132 | MP0002419_abnormal_innate_immunity | 0.68003044 |
133 | MP0003567_abnormal_fetal_cardiomyocyte | 0.66911307 |
134 | MP0005647_abnormal_sex_gland | 0.65981607 |
135 | MP0002006_tumorigenesis | 0.65084288 |
136 | MP0000477_abnormal_intestine_morphology | 0.64883829 |
137 | MP0005646_abnormal_pituitary_gland | 0.64728741 |
138 | MP0000858_altered_metastatic_potential | 0.62500321 |
139 | MP0002136_abnormal_kidney_physiology | 0.61344019 |
140 | MP0008874_decreased_physiological_sensi | 0.60831629 |
141 | MP0005410_abnormal_fertilization | 0.60362740 |
142 | MP0002822_catalepsy | 0.60136074 |
143 | MP0003453_abnormal_keratinocyte_physiol | 0.58782135 |
144 | MP0003690_abnormal_glial_cell | 0.58640242 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormal number of erythroid precursors (HP:0012131) | 6.49847040 |
2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.39507250 |
3 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 6.06086200 |
4 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.98405378 |
5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.98405378 |
6 | Abnormality of glycolipid metabolism (HP:0010969) | 5.98405378 |
7 | Systemic lupus erythematosus (HP:0002725) | 5.02968698 |
8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.62834291 |
9 | Aplastic anemia (HP:0001915) | 4.36649748 |
10 | Increased cerebral lipofuscin (HP:0011813) | 4.19354256 |
11 | Vacuolated lymphocytes (HP:0001922) | 4.13186126 |
12 | Prolonged bleeding time (HP:0003010) | 4.06415004 |
13 | Petechiae (HP:0000967) | 4.01745092 |
14 | Complement deficiency (HP:0004431) | 3.95783028 |
15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.87792212 |
16 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.80651355 |
17 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.80651355 |
18 | Hepatic necrosis (HP:0002605) | 3.66824690 |
19 | Increased intramyocellular lipid droplets (HP:0012240) | 3.62965201 |
20 | Pallor (HP:0000980) | 3.61068216 |
21 | Reticulocytopenia (HP:0001896) | 3.59530014 |
22 | Increased muscle lipid content (HP:0009058) | 3.56078892 |
23 | Hepatocellular necrosis (HP:0001404) | 3.49729844 |
24 | Glomerulonephritis (HP:0000099) | 3.46199192 |
25 | Dysostosis multiplex (HP:0000943) | 3.37874063 |
26 | Lipid accumulation in hepatocytes (HP:0006561) | 3.29767394 |
27 | Thrombocytosis (HP:0001894) | 3.26043109 |
28 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.24902920 |
29 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.24902920 |
30 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.24902920 |
31 | Macrocytic anemia (HP:0001972) | 3.23608026 |
32 | Reduced antithrombin III activity (HP:0001976) | 3.21235569 |
33 | Prolonged neonatal jaundice (HP:0006579) | 3.16630030 |
34 | Epistaxis (HP:0000421) | 3.15546798 |
35 | Increased hepatocellular lipid droplets (HP:0006565) | 3.15493023 |
36 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.14989409 |
37 | Abnormality of complement system (HP:0005339) | 3.12317490 |
38 | 3-Methylglutaconic aciduria (HP:0003535) | 3.04171718 |
39 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.01946044 |
40 | Mucopolysacchariduria (HP:0008155) | 3.01258466 |
41 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.01258466 |
42 | Mitochondrial inheritance (HP:0001427) | 2.92754720 |
43 | Generalized aminoaciduria (HP:0002909) | 2.92062922 |
44 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.91008005 |
45 | Intrahepatic cholestasis (HP:0001406) | 2.89451501 |
46 | Type I transferrin isoform profile (HP:0003642) | 2.84693588 |
47 | Hyperammonemia (HP:0001987) | 2.81962506 |
48 | Hypobetalipoproteinemia (HP:0003563) | 2.80753017 |
49 | Abnormal platelet function (HP:0011869) | 2.79964022 |
50 | Impaired platelet aggregation (HP:0003540) | 2.79964022 |
51 | Hyperbilirubinemia (HP:0002904) | 2.79262499 |
52 | Purpura (HP:0000979) | 2.78305073 |
53 | Increased CSF lactate (HP:0002490) | 2.76648064 |
54 | Renal Fanconi syndrome (HP:0001994) | 2.74942458 |
55 | Loss of speech (HP:0002371) | 2.74869133 |
56 | Lactic acidosis (HP:0003128) | 2.74866345 |
57 | Increased serum lactate (HP:0002151) | 2.73907413 |
58 | Increased serum ferritin (HP:0003281) | 2.71673015 |
59 | Microcytic anemia (HP:0001935) | 2.71102175 |
60 | Acanthocytosis (HP:0001927) | 2.70242687 |
61 | Dicarboxylic aciduria (HP:0003215) | 2.67545108 |
62 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.67545108 |
63 | Hyperthyroidism (HP:0000836) | 2.67276417 |
64 | Muscle fiber atrophy (HP:0100295) | 2.66048018 |
65 | Type 2 muscle fiber atrophy (HP:0003554) | 2.65865590 |
66 | Abnormal gallbladder physiology (HP:0012438) | 2.63251311 |
67 | Cholecystitis (HP:0001082) | 2.63251311 |
68 | Progressive neurologic deterioration (HP:0002344) | 2.62371906 |
69 | Hypoglycemic coma (HP:0001325) | 2.62231883 |
70 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.56559394 |
71 | Abnormality of the intrinsic pathway (HP:0010989) | 2.55244543 |
72 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.51982608 |
73 | Gingival bleeding (HP:0000225) | 2.51260698 |
74 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.50067619 |
75 | Axonal loss (HP:0003447) | 2.47111376 |
76 | Acute encephalopathy (HP:0006846) | 2.46430360 |
77 | IgM deficiency (HP:0002850) | 2.44992332 |
78 | Prolonged partial thromboplastin time (HP:0003645) | 2.44478381 |
79 | Exertional dyspnea (HP:0002875) | 2.42385337 |
80 | Cerebral edema (HP:0002181) | 2.41072050 |
81 | Ragged-red muscle fibers (HP:0003200) | 2.40652034 |
82 | Nuclear cataract (HP:0100018) | 2.40524713 |
83 | Abnormality of iron homeostasis (HP:0011031) | 2.40514725 |
84 | Menorrhagia (HP:0000132) | 2.40352257 |
85 | Oral leukoplakia (HP:0002745) | 2.37935641 |
86 | Abnormal protein glycosylation (HP:0012346) | 2.37302636 |
87 | Abnormal glycosylation (HP:0012345) | 2.37302636 |
88 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.37302636 |
89 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.37302636 |
90 | Acute necrotizing encephalopathy (HP:0006965) | 2.34486253 |
91 | Ketosis (HP:0001946) | 2.31390063 |
92 | Nausea (HP:0002018) | 2.31114675 |
93 | Abnormality of methionine metabolism (HP:0010901) | 2.29323948 |
94 | Pancytopenia (HP:0001876) | 2.29079171 |
95 | Hypertensive crisis (HP:0100735) | 2.27703292 |
96 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.27285419 |
97 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.24334563 |
98 | Abnormality of reticulocytes (HP:0004312) | 2.23551478 |
99 | Glycosuria (HP:0003076) | 2.22670330 |
100 | Abnormality of urine glucose concentration (HP:0011016) | 2.22670330 |
101 | Chronic otitis media (HP:0000389) | 2.22257726 |
102 | Recurrent abscess formation (HP:0002722) | 2.21086304 |
103 | Mesangial abnormality (HP:0001966) | 2.20678061 |
104 | Retinal atrophy (HP:0001105) | 2.19955647 |
105 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.19345564 |
106 | Poikilocytosis (HP:0004447) | 2.18275389 |
107 | Delayed CNS myelination (HP:0002188) | 2.18102193 |
108 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.17948039 |
109 | J-shaped sella turcica (HP:0002680) | 2.15713529 |
110 | Respiratory difficulties (HP:0002880) | 2.15367490 |
111 | Microvesicular hepatic steatosis (HP:0001414) | 2.15353436 |
112 | Lethargy (HP:0001254) | 2.15273296 |
113 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.13102194 |
114 | Mutism (HP:0002300) | 2.12833208 |
115 | Cardiomegaly (HP:0001640) | 2.12630925 |
116 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.08097147 |
117 | Sensorimotor neuropathy (HP:0007141) | 2.07835557 |
118 | Abnormality of serum amino acid levels (HP:0003112) | 2.06992589 |
119 | Conjugated hyperbilirubinemia (HP:0002908) | 2.06657261 |
120 | Hypokinesia (HP:0002375) | 2.06393876 |
121 | Cholelithiasis (HP:0001081) | 2.06370104 |
122 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.05779276 |
123 | Recurrent bacterial skin infections (HP:0005406) | 2.05686435 |
124 | Exercise intolerance (HP:0003546) | 2.04833192 |
125 | Microretrognathia (HP:0000308) | 2.04323147 |
126 | Brushfield spots (HP:0001088) | 2.04060728 |
127 | Xanthomatosis (HP:0000991) | 2.02443744 |
128 | Late onset (HP:0003584) | 2.02322836 |
129 | Progressive muscle weakness (HP:0003323) | 2.00210417 |
130 | Amyloidosis (HP:0011034) | 1.99798893 |
131 | Hyperlipoproteinemia (HP:0010980) | 1.99457488 |
132 | Abnormality of the common coagulation pathway (HP:0010990) | 1.99410174 |
133 | Abnormal pupillary function (HP:0007686) | 1.98084817 |
134 | Obstructive lung disease (HP:0006536) | 1.98056258 |
135 | Chronic obstructive pulmonary disease (HP:0006510) | 1.98056258 |
136 | Disinhibition (HP:0000734) | 1.97145163 |
137 | Vertebral compression fractures (HP:0002953) | 1.96469697 |
138 | Nephritis (HP:0000123) | 1.94712292 |
139 | Respiratory failure (HP:0002878) | 1.94465116 |
140 | Deep venous thrombosis (HP:0002625) | 1.92627540 |
141 | Metabolic acidosis (HP:0001942) | 1.91566806 |
142 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.90443512 |
143 | Progressive macrocephaly (HP:0004481) | 1.90025539 |
144 | Upper motor neuron abnormality (HP:0002127) | 1.88686821 |
145 | Abnormal gallbladder morphology (HP:0012437) | 1.88666095 |
146 | Joint hemorrhage (HP:0005261) | 1.87496186 |
147 | Cerebral palsy (HP:0100021) | 1.86317208 |
148 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.86002999 |
149 | 11 pairs of ribs (HP:0000878) | 1.85917636 |
150 | Vomiting (HP:0002013) | 1.85156088 |
151 | Hyperglycinemia (HP:0002154) | 1.84062666 |
152 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.83914557 |
153 | Hyperalaninemia (HP:0003348) | 1.82176657 |
154 | Truncus arteriosus (HP:0001660) | 1.78685042 |
155 | Double outlet right ventricle (HP:0001719) | 1.78261408 |
156 | Congenital malformation of the right heart (HP:0011723) | 1.78261408 |
157 | Abnormality of macrophages (HP:0004311) | 1.78157255 |
158 | Delusions (HP:0000746) | 1.77625702 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK16 | 4.41023559 |
2 | VRK2 | 4.22468412 |
3 | MUSK | 3.86763089 |
4 | NME2 | 3.83601217 |
5 | BCKDK | 3.21867067 |
6 | CDK19 | 2.74121256 |
7 | SMG1 | 2.52307312 |
8 | TAOK2 | 2.41178636 |
9 | TGFBR1 | 2.32735472 |
10 | TESK2 | 2.31322308 |
11 | TESK1 | 2.26431224 |
12 | VRK1 | 2.24528988 |
13 | KIT | 2.21507348 |
14 | FLT3 | 2.18244065 |
15 | PRKD3 | 2.03813876 |
16 | EEF2K | 2.02133560 |
17 | WEE1 | 2.01784378 |
18 | PKN2 | 2.01725616 |
19 | TAF1 | 1.98224196 |
20 | MAP3K12 | 1.92463404 |
21 | MAP2K3 | 1.92355018 |
22 | MAP4K1 | 1.86246596 |
23 | PIM2 | 1.82205503 |
24 | TIE1 | 1.81249837 |
25 | SCYL2 | 1.78429188 |
26 | DYRK3 | 1.72825200 |
27 | LIMK1 | 1.72267157 |
28 | RPS6KB2 | 1.71971425 |
29 | KDR | 1.68130602 |
30 | MAPKAPK3 | 1.67315071 |
31 | TAOK3 | 1.64644496 |
32 | MATK | 1.61982246 |
33 | TGFBR2 | 1.56087936 |
34 | PRKG2 | 1.53780551 |
35 | MAPKAPK5 | 1.53395168 |
36 | TNIK | 1.53036605 |
37 | MAP2K6 | 1.52351747 |
38 | EIF2AK1 | 1.52160351 |
39 | ARAF | 1.44308413 |
40 | BTK | 1.42688960 |
41 | ERN1 | 1.42169981 |
42 | TEC | 1.27536020 |
43 | ACVR1B | 1.27340404 |
44 | TBK1 | 1.26283542 |
45 | GRK7 | 1.25093406 |
46 | PASK | 1.23474712 |
47 | MYLK | 1.19615482 |
48 | CDK8 | 1.19104092 |
49 | JAK3 | 1.12698522 |
50 | DAPK3 | 1.12018978 |
51 | ZAP70 | 1.11117340 |
52 | IRAK3 | 1.10285448 |
53 | EPHA2 | 1.09358381 |
54 | EPHB2 | 1.08462800 |
55 | MAP3K11 | 1.07551095 |
56 | CSNK1G2 | 1.07089315 |
57 | CSNK1A1L | 1.03736411 |
58 | TNK2 | 1.02704496 |
59 | LRRK2 | 1.00504371 |
60 | BRSK2 | 0.97863332 |
61 | PINK1 | 0.97412733 |
62 | SRPK1 | 0.96690607 |
63 | ADRBK2 | 0.94791773 |
64 | TAOK1 | 0.93461108 |
65 | EIF2AK3 | 0.92452984 |
66 | IRAK2 | 0.92228001 |
67 | IRAK4 | 0.90742991 |
68 | MKNK1 | 0.90312310 |
69 | RPS6KA4 | 0.89948011 |
70 | LMTK2 | 0.88457364 |
71 | IKBKE | 0.87747855 |
72 | BLK | 0.86903829 |
73 | CCNB1 | 0.83286982 |
74 | NME1 | 0.81448416 |
75 | TLK1 | 0.80777271 |
76 | CSF1R | 0.78777320 |
77 | CDK7 | 0.77391547 |
78 | NEK9 | 0.76710926 |
79 | SIK1 | 0.76107871 |
80 | PBK | 0.75955768 |
81 | TRIB3 | 0.75706440 |
82 | MAPK11 | 0.73786695 |
83 | SYK | 0.72672052 |
84 | MAP3K7 | 0.72492521 |
85 | TYK2 | 0.70609294 |
86 | PIK3CG | 0.69810819 |
87 | CAMK1 | 0.69579850 |
88 | MAP3K1 | 0.68185216 |
89 | CDC7 | 0.67833921 |
90 | PRKCI | 0.67699488 |
91 | PIM1 | 0.67218874 |
92 | MAP2K2 | 0.67143712 |
93 | DDR2 | 0.66655943 |
94 | DAPK1 | 0.66220298 |
95 | NUAK1 | 0.66058898 |
96 | ILK | 0.65720718 |
97 | ICK | 0.64162334 |
98 | PDK2 | 0.62886520 |
99 | PAK4 | 0.61973061 |
100 | NEK2 | 0.61677246 |
101 | MAP3K3 | 0.59061868 |
102 | LYN | 0.58604029 |
103 | PRPF4B | 0.58110296 |
104 | CAMKK2 | 0.56154154 |
105 | DYRK2 | 0.56148571 |
106 | CDK9 | 0.54992236 |
107 | MAPK4 | 0.54978906 |
108 | IKBKB | 0.53748648 |
109 | MAPK15 | 0.53718802 |
110 | FGFR4 | 0.53663640 |
111 | AURKB | 0.52730607 |
112 | JAK2 | 0.52250515 |
113 | GRK5 | 0.51381870 |
114 | NLK | 0.51012059 |
115 | CAMK1D | 0.50541904 |
116 | GRK1 | 0.48627139 |
117 | ATR | 0.48393371 |
118 | TXK | 0.48275549 |
119 | CSNK1G3 | 0.46883872 |
120 | CHUK | 0.46435069 |
121 | CDK4 | 0.45861869 |
122 | ABL2 | 0.45606051 |
123 | GSK3A | 0.43616241 |
124 | MAP2K7 | 0.43006769 |
125 | CAMK2G | 0.42914801 |
126 | CSNK2A1 | 0.41232651 |
127 | CSNK2A2 | 0.40690118 |
128 | RPS6KL1 | 0.39616128 |
129 | RPS6KC1 | 0.39616128 |
130 | MST1R | 0.39272819 |
131 | BRAF | 0.37150057 |
132 | MAP3K5 | 0.36579779 |
133 | CAMK2D | 0.35760123 |
134 | DYRK1B | 0.34196812 |
135 | RPS6KA6 | 0.32866353 |
136 | CSNK1G1 | 0.31768945 |
137 | PLK1 | 0.31105561 |
138 | MAP3K14 | 0.31048094 |
139 | CSNK1A1 | 0.30533555 |
140 | MAPK3 | 0.30365611 |
141 | PRKCD | 0.29924481 |
142 | RPS6KA5 | 0.29779409 |
143 | AURKA | 0.29717020 |
144 | PDPK1 | 0.29021150 |
145 | HIPK2 | 0.28130058 |
146 | RPS6KA2 | 0.27330929 |
147 | PAK1 | 0.27083509 |
148 | GRK6 | 0.27045916 |
149 | TSSK6 | 0.26546099 |
150 | ERBB2 | 0.24665337 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 4.71284310 |
2 | DNA replication_Homo sapiens_hsa03030 | 3.07206244 |
3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.00127488 |
4 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.70801316 |
5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.43953943 |
6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.41523225 |
7 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.30839876 |
8 | Mismatch repair_Homo sapiens_hsa03430 | 2.15970920 |
9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.09908876 |
10 | Lysosome_Homo sapiens_hsa04142 | 2.09284210 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.06785171 |
12 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.04418074 |
13 | Sulfur relay system_Homo sapiens_hsa04122 | 1.99674804 |
14 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.95092209 |
15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.87093500 |
16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79063685 |
17 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.78484614 |
18 | RNA polymerase_Homo sapiens_hsa03020 | 1.71236912 |
19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.70672603 |
20 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.67138739 |
21 | Proteasome_Homo sapiens_hsa03050 | 1.64294880 |
22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.62342625 |
23 | Peroxisome_Homo sapiens_hsa04146 | 1.62132303 |
24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.61004382 |
25 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.60545900 |
26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.58530529 |
27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.53883214 |
28 | Protein export_Homo sapiens_hsa03060 | 1.48955815 |
29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.48874036 |
30 | * Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.47442762 |
31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.44304180 |
32 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.44103510 |
33 | Base excision repair_Homo sapiens_hsa03410 | 1.42572779 |
34 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.41917649 |
35 | Homologous recombination_Homo sapiens_hsa03440 | 1.39977333 |
36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.39613404 |
37 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.36215391 |
38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.30844903 |
39 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.30591272 |
40 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.30015458 |
41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29593032 |
42 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.25830839 |
43 | Spliceosome_Homo sapiens_hsa03040 | 1.20404881 |
44 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.17203286 |
45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.14418409 |
46 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.13543006 |
47 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.11798415 |
48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.10921392 |
49 | * Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.10343608 |
50 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.07939825 |
51 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.06742431 |
52 | Histidine metabolism_Homo sapiens_hsa00340 | 1.05869331 |
53 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.04661851 |
54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.04630649 |
55 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.03359523 |
56 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.02856579 |
57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02211578 |
58 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.01779146 |
59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.01228941 |
60 | Huntingtons disease_Homo sapiens_hsa05016 | 0.99881380 |
61 | Asthma_Homo sapiens_hsa05310 | 0.99437070 |
62 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99134334 |
63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.98787888 |
64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.98381003 |
65 | Prion diseases_Homo sapiens_hsa05020 | 0.97863779 |
66 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.97525897 |
67 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.96532853 |
68 | Purine metabolism_Homo sapiens_hsa00230 | 0.95968324 |
69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.93980499 |
70 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.93746725 |
71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.92059822 |
72 | Alzheimers disease_Homo sapiens_hsa05010 | 0.91823076 |
73 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.89537902 |
74 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.89339760 |
75 | ABC transporters_Homo sapiens_hsa02010 | 0.88056414 |
76 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.87336339 |
77 | RNA degradation_Homo sapiens_hsa03018 | 0.87270510 |
78 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84753023 |
79 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.84575313 |
80 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84187303 |
81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81828077 |
82 | Retinol metabolism_Homo sapiens_hsa00830 | 0.81388414 |
83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.81338729 |
84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80829617 |
85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79956666 |
86 | Pertussis_Homo sapiens_hsa05133 | 0.79672883 |
87 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.79502337 |
88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70968223 |
89 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.70691793 |
90 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.70649978 |
91 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.69845108 |
92 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65960675 |
93 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65124057 |
94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64052996 |
95 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.62116822 |
96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.60185315 |
97 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60167096 |
98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.57010921 |
99 | RNA transport_Homo sapiens_hsa03013 | 0.56243096 |
100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55151264 |
101 | Allograft rejection_Homo sapiens_hsa05330 | 0.54906314 |
102 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.50432366 |
103 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50170230 |
104 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.49046836 |
105 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.48973871 |
106 | Mineral absorption_Homo sapiens_hsa04978 | 0.48719002 |
107 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.45760807 |
108 | Phagosome_Homo sapiens_hsa04145 | 0.43873066 |
109 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43381212 |
110 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.42628164 |
111 | Bile secretion_Homo sapiens_hsa04976 | 0.40457166 |
112 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.40423037 |
113 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.40170866 |
114 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.39909862 |
115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38565333 |
116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38323183 |
117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36699894 |
118 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.36505715 |
119 | Tuberculosis_Homo sapiens_hsa05152 | 0.35599157 |
120 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.34632010 |
121 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.34391967 |
122 | Cell cycle_Homo sapiens_hsa04110 | 0.33749306 |
123 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.33548840 |
124 | Leishmaniasis_Homo sapiens_hsa05140 | 0.33352706 |
125 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.32937992 |
126 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.31051779 |
127 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.28725379 |